2294 part 1 final report.pdf - Agra CEAS Consulting
2294 part 1 final report.pdf - Agra CEAS Consulting
2294 part 1 final report.pdf - Agra CEAS Consulting
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Prevention and control of animal diseases worldwide<br />
Part I: Economic analysis: prevention versus outbreak costs<br />
Two emerging economies account for 9.6% of trade in beef (by value): Brazil with 6.7% and Argentina<br />
with 2.9% (Uruguay, a developing country, accounts for 2.3% of trade). Finally, four developing or<br />
emerging economies countries account for 8.7% of trade in pigmeat (by value): Brazil with 3.8%, China<br />
with 2%, Hungary with 1.7% and Mexico with 1.4%.<br />
Figure 1 Share of global livestock product exports by key world regions (by value)<br />
Share of livestock Export<br />
85.0%<br />
80.0%<br />
75.0%<br />
70.0%<br />
65.0%<br />
60.0%<br />
55.0%<br />
50.0%<br />
45.0%<br />
40.0%<br />
35.0%<br />
30.0%<br />
25.0%<br />
20.0%<br />
15.0%<br />
10.0%<br />
5.0%<br />
0.0%<br />
Developed Countries<br />
Newly industrialized<br />
countries<br />
Emerging Economies<br />
Developing Country<br />
Source: UN COMTRADE data<br />
It is widely acknowledged in the available literature that big gains are possible for the developing<br />
countries from removal of sanitary barriers now that post URAA tariff barriers have been reduced (e.g.<br />
A141); these opportunities are likely to expand if tariff barriers are further reduced in the ongoing WTO<br />
and bilateral negotiations. Within this evolving policy outlook, the improvement in SPS conditions for<br />
developing country exporters or potential exporters has become an issue of utmost importance (as well as<br />
being an obligation under the WTO SPS Agreement).<br />
Furthermore, benefits are expected to accrue in terms of the potential savings to be made in outbreak costs<br />
from the fact that with improved prevention and veterinary services such outbreaks can be avoided<br />
altogether or their frequency reduced or at the very least their costs can be minimised. However, it is<br />
important to note that currently the cost-benefit of any investment aiming to improve early<br />
detection/diagnosis would tend to be unreliable as at present there are no accurate epidemiological<br />
modelling studies in the developing world of the rate of disease spread with late diagnosis versus early<br />
diagnosis (see for e.g. A7). Similarly, there is limited data and information on certain suspected risk<br />
Civic <strong>Consulting</strong> • <strong>Agra</strong> <strong>CEAS</strong> <strong>Consulting</strong> 38